The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sigal E.I.

Republican Clinical Cancer Center, Kazan, Republic of Tatarstan, Russia

Sigal, A.M.

Respublikanskiĭ klinicheskiĭ onkologicheskiĭ dispanser Ministerstva zdravookhraneniia Respubliki Tatarstan, Kazan'

Sigal R.E.

Kazan City Oncology Center, Kazan, Russia

Burmistrov M.V.

Republican Clinical Cancer Center, Kazan, Republic of Tatarstan, Russia

Bikbaeva V.R.

Republican Clinical Oncology Center, Ministry of Health of the Republic of Tatarstan, Kazan, Russia

The role of plasmapheresis in prevention of complications after thoracoscopic thymectomy in patients with myasthenia combined with thymic hyperplasia

Authors:

Sigal E.I., Sigal, A.M., Sigal R.E., Burmistrov M.V., Bikbaeva V.R.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2016;(11): 36‑40

Read: 1311 times


To cite this article:

Sigal EI, Sigal, AM, Sigal RE, Burmistrov MV, Bikbaeva VR. The role of plasmapheresis in prevention of complications after thoracoscopic thymectomy in patients with myasthenia combined with thymic hyperplasia. Pirogov Russian Journal of Surgery. 2016;(11):36‑40. (In Russ.)
https://doi.org/10.17116/hirurgia201611236-40

References:

  1. Skvorcov M.B., Smolin A.I. Miastenija. Hirurgicheskoe lechenie i ego jeffektivnost'. Bjulleten' Vostochno-Sibirskogo nauchnogo centra SO RAMN. 2012;4-1.
  2. Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS. Thymectomy: role in the treatment of myasthenia gravis. Journal of neurology. 2013;260:7:1798-1801.
  3. Ando T, Omasa M, Kondo T, Yamada T, Sato M, Menju T, Date H. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis. European Journal of Cardio-Thoracic Surgery. 2015;48:5:705-709.
  4. Romanova T.V., Beljakova M.Ju., Pushkin S.Ju., Reshetov A.P. Ocenka jeffektivnosti timjektomii u pacientov s miasteniej. Saratovskij nauchno-medicinskij zhurnal. 2009;5:2.
  5. Tsukada H et al. Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis. The Annals of thoracic surgery. 2014;97:6:2175-2177.
  6. Kosachev V.D., Zhulev N.M., Bechik S.L. Obmennyj plazmaferez v kompleksnom lechenii miastenii. Jefferentnaja terapija. 2006;12:2:28-31.
  7. Furlan JC, Barth D, Barnett C, Bril V. Cost‐minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis. Muscle & nerve. 2015.
  8. Barnett C, Katzberg HD, Keshavjee S, Bril V. Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study. Orphanet journal of rare diseases. 2014;9:1:1.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.